Table 1 .
Baseline Demographic Information—All ASC-US Subjects
| Characteristic | Total Subjects (n = 1,960), % (No.) |
|---|---|
| Age, y | |
| Mean (SD) | 36.2 ± 11.5 |
| Median | 34.0 |
| 21-29 | 37.3 (732) |
| 30-39 | 26.6 (521) |
| ≥40 | 36.1 (707) |
| Race | |
| Asian | 1.0 (20) |
| African American | 23.4 (459) |
| White | 73.8 (1,446) |
| Othera | 1.8 (35) |
| Ethnicity | |
| Hispanic or Latino | 15.5 (303) |
| Not Hispanic or Latino | 84.5 (1,657) |
| Smoking history | |
| Nonsmoker | 66.5 (1,304) |
| Current | 15.7 (308) |
| Past | 17.8 (348) |
| HPV vaccinated | |
| Yes | 11.4 (224) |
| No | 86.6 (1,698) |
| Unknown | 1.9 (38) |
| Postmenopausal | 12.7 (249) |
| Immunocompromised | 1.9 (37) |
| Abnormal cytology (past 5 y) | 26.5 (519) |
| Colposcopy (past 5 y) | 16.3 (319) |
| HPV status (n = 1,953)b | |
| Any HPV | 39.1 (763) |
| HPV 16 | 7.4 (144) |
| HPV 18c | 2.5 (48) |
| HPV 45c | 2.4 (47) |
| 11 “other” HPV | 32.2 (629) |
| HPV negative | 60.9 (1,190) |
ASC-US, atypical squamous cells-undetermined significance; HPV, human papillomavirus; SD, standard deviation.
aIncludes American Indian, Alaska Native, Native Hawaiian, or other Pacific Islander.
bSeven specimens missing Onclarity HPV results.
cHPV 18 value includes HPV 16; HPV 45 value includes HPV 16 and 18.